Discovering and Optimizing First-in-Class Biologics
The Engineering stream profiles the rapid advancements in biologic drug development and provides unparalleled knowledge and collaboration opportunities. This year’s list of hot topics includes deep sequencing of antibody repertoires, single cell analysis, yeast and phage display for antibody discovery, tools for designing “smart” antibodies including AI and machine learning, improving targeting specificity, overcoming liabilities, next generation libraries, targeting membrane proteins, engineering bispecific antibodies for oncology and beyond. Plan to attend and learn why this has become the industry’s leading event in biotherapeutics.
David Gifford, PhD Professor, Computer Science and Biological Engineering, MIT
Janice Reichert, PhD Executive Director, The Antibody Society
Dimitris Skokos, PhD Director, Immune & Inflammatory Diseases, Regeneron Pharmaceuticals
James Wells, PhD Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco